BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12842047)

  • 1. Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm.
    Kang BS; Cooper DR; Devedjiev Y; Derewenda U; Derewenda ZS
    Structure; 2003 Jul; 11(7):845-53. PubMed ID: 12842047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
    Grootjans JJ; Reekmans G; Ceulemans H; David G
    J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDZ tandem of human syntenin: crystal structure and functional properties.
    Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
    Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
    Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
    Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
    Grootjans JJ; Zimmermann P; Reekmans G; Smets A; Degeest G; Dürr J; David G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13683-8. PubMed ID: 9391086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
    Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
    Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of the PDZ tandem of syntenin to target proteins.
    Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
    Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PDZ2 domain of syntenin at ultra-high resolution: bridging the gap between macromolecular and small molecule crystallography.
    Kang BS; Devedjiev Y; Derewenda U; Derewenda ZS
    J Mol Biol; 2004 Apr; 338(3):483-93. PubMed ID: 15081807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif.
    Lin D; Gish GD; Songyang Z; Pawson T
    J Biol Chem; 1999 Feb; 274(6):3726-33. PubMed ID: 9920925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane.
    Zimmermann P; Meerschaert K; Reekmans G; Leenaerts I; Small JV; Vandekerckhove J; David G; Gettemans J
    Mol Cell; 2002 Jun; 9(6):1215-25. PubMed ID: 12086619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat protein tyrosine phosphatase eta physically interacts with the PDZ domains of syntenin.
    Iuliano R; Trapasso F; Samà I; Le Pera I; Martelli ML; Lembo F; Santoro M; Viglietto G; Chiariotti L; Fusco A
    FEBS Lett; 2001 Jun; 500(1-2):41-4. PubMed ID: 11434923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
    Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
    Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
    von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K
    FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.
    Fernández-Larrea J; Merlos-Suárez A; Ureña JM; Baselga J; Arribas J
    Mol Cell; 1999 Apr; 3(4):423-33. PubMed ID: 10230395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
    Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
    Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions.
    Mortier E; Wuytens G; Leenaerts I; Hannes F; Heung MY; Degeest G; David G; Zimmermann P
    EMBO J; 2005 Jul; 24(14):2556-65. PubMed ID: 15961997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells.
    Cohen AR; Woods DF; Marfatia SM; Walther Z; Chishti AH; Anderson JM
    J Cell Biol; 1998 Jul; 142(1):129-38. PubMed ID: 9660868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.
    Geijsen N; Uings IJ; Pals C; Armstrong J; McKinnon M; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Science; 2001 Aug; 293(5532):1136-8. PubMed ID: 11498591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
    Sugi T; Oyama T; Morikawa K; Jingami H
    Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-amino acid substitutions alter the specificity and affinity of PDZ domains for their ligands.
    Gee SH; Quenneville S; Lombardo CR; Chabot J
    Biochemistry; 2000 Nov; 39(47):14638-46. PubMed ID: 11087420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.